Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
28 Novembre 2023 - 2:00PM
Business Wire
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in
serving science, and Flagship Pioneering, the bioplatform
innovation company, today announced the formation of a strategic
partnership to develop and commercially scale multiproduct
platforms on an accelerated basis.
Through this collaboration, Thermo Fisher and Flagship will work
together to create new platform companies focusing on novel tools
and capabilities that seek to power the biotech ecosystem and
accelerate the development of first-in-class therapies. The newly
formed strategic partnership is an expansion of the long-standing
supply relationship between Thermo Fisher and Flagship, which
extends to Flagship’s ecosystem of companies and leverages the
expertise of both organizations including the areas of life science
tools, diagnostics, and services.
“As the trusted partner in our industry, collaborating on
innovation is an important evolution of the long-standing
relationship between our companies,” said Michel Lagarde, executive
vice president and chief operating officer, Thermo Fisher
Scientific. “We look forward to seeing the accelerating effect of
Thermo Fisher’s deep technical expertise and extensive commercial
capabilities on the future innovations Flagship and its companies
will bring to market.”
“Pioneering new modalities for human health and environmental
health require complementary capabilities and ecosystem elements to
realize the full potential,” said Justine Levin-Allerhand, Ph.D.,
Flagship Pioneering Senior Partner. “Our partnership will couple
Flagship’s innovative company formation process with Thermo
Fisher’s deep understanding of the life sciences industry, as we
collaborate to develop transformative capabilities for the
ecosystem. We are pleased to expand our relationship with Thermo
Fisher and together take bigger leaps in life sciences
capabilities, while further empowering our industry.”
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving
science, with annual revenue over $40 billion. Our Mission is to
enable our customers to make the world healthier, cleaner and
safer. Whether our customers are accelerating life sciences
research, solving complex analytical challenges, increasing
productivity in their laboratories, improving patient health
through diagnostics or the development and manufacture of
life-changing therapies, we are here to support them. Our global
team delivers an unrivaled combination of innovative technologies,
purchasing convenience and pharmaceutical services through our
industry-leading brands, including Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services,
Patheon and PPD.
About Flagship Pioneering
Flagship Pioneering is a biotechnology company that invents and
builds platform companies, each with the potential for multiple
products that transform human health or sustainability. Since its
launch in 2000, Flagship has originated and fostered more than 100
scientific ventures, resulting in more than $90 billion in
aggregate value. To date, Flagship has deployed over $3.4 billion
in capital toward the founding and growth of its pioneering
companies alongside more than $26 billion of follow-on investments
from other institutions. The current Flagship ecosystem comprises
40 companies, including Denali Therapeutics (NASDAQ: DNLI), Foghorn
Therapeutics (NASDAQ: FHTX), Generate:Biomedicines, Inari, Indigo
Agriculture, Moderna (NASDAQ: MRNA), Omega Therapeutics (NASDAQ:
OMGA), Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics
(NASDAQ: MCRB) and Tessera Therapeutics.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231128400906/en/
Media Contact Information: Sandy Pound Phone: 781-622-1223
E-mail: sandy.pound@thermofisher.com Investor Contact Information:
Rafael Tejada Phone: 781-622-1356 E-mail:
rafael.tejada@thermofisher.com Flagship Pioneering:
press@flagshippioneering.com
Grafico Azioni Thermo Fisher Scientific (NYSE:TMO)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Thermo Fisher Scientific (NYSE:TMO)
Storico
Da Mag 2023 a Mag 2024